Qualitative Interviews with Stakeholders in Herbal Pharmacovigilance and Recommendations for Best Practices to be Applied Worldwide.

Autor: Ekhart C; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH's, Hertogenbosch, The Netherlands. c.ekhart@lareb.nl., Wiarda SHP; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH's, Hertogenbosch, The Netherlands.; Department of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, The Netherlands., van de Koppel S; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH's, Hertogenbosch, The Netherlands., Skalli S; Faculty of Science Mohammed V University, Rabat, Morocco., Alghamdi W; Pharmacovigilance Directorate, Saudi Food and Drug Authority, Riyadh, Saudi Arabia., Menniti-Ippolito F; Italian National Institute of Health, Rome, Italy., Tangchitkhachon K; Praboromarajchanok Institute Ministry of Public Health, Nonthaburi, Thailand., Mponda JS; Pharmacy Department, Kamuzu University of Health Sciences, Blantyre, Malawi.; Africa Centre of Excellence in Public Health and Herbal Medicine, Kamuzu University of Health Sciences, Blantyre, Malawi., Woerdenbag HJ; Department of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, The Netherlands., van Hunsel F; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH's, Hertogenbosch, The Netherlands.; Department of PharmacoTherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, The Netherlands.

Publikováno v: Drug safety [Drug Saf] 2024 Sep 12. Date of Electronic Publication: 2024 Sep 12.

Ippolito F (prof tutor) con Tavoletta C (dottorando co-tutor), D’Addio F, Diana V, di Renna F, Gallo M, Picone V, Saulino A, Tartaglione E (studenti), Workshop Rigenerare ASI Gruppo 9

Autor: IPPOLITO, Fabrizia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3977::71e973ac1eacd18dfb0a7e0dc8864a53
http://hdl.handle.net/11591/167299

Acute Appendicitis After COVID-19 Vaccines in Italy: A Self-Controlled Case Series Study.

Autor: Morciano C; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Massari M; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Cutillo M; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Belleudi V; Department of Epidemiology ASL Roma 1, Lazio Regional Health Service, Rome, Italy., Trifirò G; Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Mores N; Institute of Pharmacology, Pharmacovigilance, Policlinico Universitario A. Gemelli, Catholic University of Sacred Heart, Rome, Italy., Sapigni E; Hospital Assistance Service, General Directorate for Personal Care, Health and Welfare, Emilia-Romagna Region, Bologna, Italy., Puccini A; Hospital Assistance Service, General Directorate for Personal Care, Health and Welfare, Emilia-Romagna Region, Bologna, Italy., Zanoni G; Immunology Unit, University Hospital, Verona, Italy., Zorzi M; Cancer Registry of Veneto, Azienda Zero, Padua, Italy., Monaco G; Department of Health of Lombardy Region, Epidemiology Observatory, Milan, Italy., Leoni O; Department of Health of Lombardy Region, Epidemiology Observatory, Milan, Italy., Del Zotto S; Regional Health Authority, Friuli Venezia Giulia Region, Udine, Italy., Samez S; Regional Pharmacovigilance Centre, Trieste, Italy., Mayer F; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Marano G; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Menniti Ippolito F; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Da Cas R; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Traversa G; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Spila Alegiani S; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy. stefania.spila@iss.it.

Publikováno v: Drug safety [Drug Saf] 2024 Nov; Vol. 47 (11), pp. 1157-1169. Date of Electronic Publication: 2024 Jul 27.

Suspected adverse reactions to medications and food supplements containing Serenoa repens: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports.

Autor: Crescioli G; Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, Florence, Italy.; Tuscan Regional Centre of Pharmacovigilance, Florence, Italy., Maggini V; CERFIT, Research and Innovation Center in Phytotherapy and Integrated Medicine, Careggi University Hospital, Florence, Italy., Raschi E; Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy., Gonella LA; Department of Medicine, University of Verona, Verona, Italy., Luxi N; Department of Medicine, University of Verona, Verona, Italy., Ippoliti I; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Di Giovanni V; Italian Medicines Agency, Rome, Italy., Bonaiuti R; Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, Florence, Italy.; Tuscan Regional Centre of Pharmacovigilance, Florence, Italy., Firenzuoli N; Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy., Gallo E; CERFIT, Research and Innovation Center in Phytotherapy and Integrated Medicine, Careggi University Hospital, Florence, Italy., Menniti-Ippolito F; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Moretti U; Department of Medicine, University of Verona, Verona, Italy., Trifirò G; Department of Medicine, University of Verona, Verona, Italy., Vannacci A; Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, Florence, Italy.; Tuscan Regional Centre of Pharmacovigilance, Florence, Italy., Firenzuoli F; CERFIT, Research and Innovation Center in Phytotherapy and Integrated Medicine, Careggi University Hospital, Florence, Italy., Lombardi N; Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, Florence, Italy.; Tuscan Regional Centre of Pharmacovigilance, Florence, Italy.

Publikováno v: Phytotherapy research : PTR [Phytother Res] 2023 Nov; Vol. 37 (11), pp. 5289-5299. Date of Electronic Publication: 2023 Jul 18.

Risk of breakthrough infection and hospitalisation after COVID-19 primary vaccination by HIV status in four Italian regions during 2021.

Autor: Mateo-Urdiales A; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy. Alberto.mateourdiales@iss.it., Fabiani M; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy., Mayer F; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy., Sacco C; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.; European Programme on Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, Stockholm, Sweden., Belleudi V; Department of Epidemiology, Lazio Regional Health Service, ASL Roma 1, Rome, Italy., Da Cas R; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy., Fotakis EA; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.; European Programme on Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, Stockholm, Sweden., De Angelis L; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Cutillo M; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy., Petrone D; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy., Morciano C; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy., Cannone A; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy., Del Manso M; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy., Riccardo F; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy., Bella A; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy., Menniti-Ippolito F; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy., Pezzotti P; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy., Spila Alegiani S; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy., Massari M; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.

Publikováno v: BMC public health [BMC Public Health] 2024 Jun 11; Vol. 24 (1), pp. 1569. Date of Electronic Publication: 2024 Jun 11.